Master One Thing - Rapamycin Longevity Series cover image

Ross Pelton on Rapamycin Longevity Series | How it all began

Master One Thing - Rapamycin Longevity Series

00:00

Unveiling the Power of Rapamycin

This chapter explores groundbreaking findings from the first human clinical trial on rapamycin, particularly its dosage effects on immune function in the elderly. The discussion also includes misconceptions in the medical community, ongoing research on aging, and personal experiences that underscore the potential health benefits of rapamycin. The speaker emphasizes the importance of education for both the public and healthcare professionals in promoting awareness about rapamycin for longevity and overall health.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app